Frank LoBiondo

This strategy tracks equity positions disclosed in Frank LoBiondo's congressional financial filings submitted within 30 days of each trade. The assets distribution and weights are updated when new filings are posted

Abbott Laboratories

15%

Cisco

14%

Amgen

14%

Nike

13%

JPMorgan

13%

Blackrock, Inc.

11%

Accenture

11%

Apple

9%